Phoenix PharmaLabs
Addressing the opioid crisis by developing potent, safe, non-addictive painkillers.
Analytics
Raised to Date: $339,701
Aggregate Commitments $
Netcapital
01/31/2021
03/23/2021
$10,000
$1,070,000
$99
Equity - Common
RegCF
Seed
$26,790,283
Weekly Commitments $
Active
02/24/2021
26
3,397%
32%
$14,154
Woods Cross, Utah
Healthcare & Pharmaceuticals
HealthTech
B2B2C
High
High
Phoenix PharmaLabs, with a post-money valuation of $26,790,283, is Crowdfunding on NetCapital. The company is a preclinical drug discovery company dedicated to the development of potent, safe, non-addictive treatments for pain and addiction. John Lawson, PH.D. and Lawrence Toll, PH.D. founded Phoenix PharmaLabs. The crowdfunding round has a minimum raise of $10,000 and a maximum raise of $1,070,000. Phoenix PharmaLabs lead drug, PPL-103, has demonstrated in animal studies that it is a very potent painkiller (10x more potent than morphine), and is non-addictive, does not produce withdrawal, does not cause death from overdose at elevated doses, and causes no constipation.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$1,285,068 |
$66,654 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$100 |
| ||
| ||
|
Net Income |
$-552,876 |
$-939,817 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$761,206 |
$37,344 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$761,206 |
$37,344 |
|
Short-Term Debt |
$0 |
$1,964,449 |
|
Long-Term Debt |
$2,058,665 |
$0 |
|
Total Liabilities |
$2,058,665 |
$1,964,449 |
Summary of Crowdfunding Raises
| Close Date | Platform | Valuation/Cap | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 03/23/2021 | Netcapital | $26,790,283 | $339,701 | Equity - Common | Active | RegCF |
| 01/30/2021 | Netcapital | $26,790,283 | $0 | Equity - Common | Confirmed Closed | Test the Waters |
| 03/30/2019 | Netcapital | $23,136,335 | $1,102,553 | Equity - Common | Confirmed Closed | RegCF |
Ratings
Ratings Platform - Beta Trial
Our new ratings and analytics platform is currently in Beta. To gain access to the Beta platform features, upgrade to a Pro paid account and accept the Beta terms on any page.
For a limited time, use coupon code "TRYMERLIN20" for a free 20 day trial of Kingscrowd Pro and Merlin Beta. Your paid subscription will activate at the end of 20 days. Cancel anytime.Analyst Report
Ratings Platform - Beta Trial
Our new ratings and analytics platform is currently in Beta. To gain access to the Beta platform features, upgrade to a Pro paid account and accept the Beta terms on any page.
For a limited time, use coupon code "TRYMERLIN20" for a free 20 day trial of Kingscrowd Pro and Merlin Beta. Your paid subscription will activate at the end of 20 days. Cancel anytime.Other Deals
MedVector on StartEngine
The COVID-19 pandemic has grown the telehealth industry exponentially. A recent study of U.S medical specialists found that
C-Reveal Therapeutics on NetCapital
Cancer is the great, mysterious killer of medical science. As of January 2019, there were an
Millennial Fertility Co. on NetCapital
The Millennial Fertility Co. team has been selected as a “Deal to Watch” by KingsCrowd. This distinction is…